BMC cancer
Characterization of clinical risk factors for enhanced molecular residual disease monitoring in resected early-stage non-small cell lung cancer.
Yunfei Shi, Youming Lei, Yinqiang Liu, Wei Zhao, Qingmei Yang, Fujun Zhang, Li Bian, Xiaoyu Luo, Kang Luo, Haoyu Li, Fanghao Liu, Tingguang Wang, Yong Liu, Ya Ma, Jiani C Yin
Published: 202510.1186/s12885-025-15259-6
No abstract available for this study.